CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Scott Corley

OPENALEX: A5002837549↗ORCID: 0000-0001-5288-9188↗

Affiliations

Organizations

Royal University Hospitalauthorship · CA University of Saskatchewanauthorship · CA

Public evidence

3 connected articles

Removing barriers to accessing medical cannabis for paediatric patients.2024 · Europe PMC Dosage Related Efficacy and Tolerability of Cannabidiol in Children With Treatment-Resistant Epileptic Encephalopathy: Preliminary Results of the CARE-E Study.2019 · Europe PMC The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study: a phase 1 dosage escalation study.2018 · Europe PMC

Registered research

Connected studies

Cannabidiol in Children With Refractory Epileptic Encephalopathy: A Phase 1 Open Label Dose Escalation Study (CARE-E)nct03024827 Cannabidiol in Children With Refractory Epileptic Encephalopathy: A Phase 1 Open Label Dose Escalation Study (CARE-E)nct03024827

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Scott Corley - Medical Cannabis Research Engine